VF
KZR

Virtu Financial’s Kezar Life Sciences KZR Stock Holding History

Virtu Financial’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,566
Closed -$21K – 1641
2024
Q2 		$21K Buy
3,566
+1,317
+59% +$10K ﹤0.01% 1027
2024
Q1 		$20K Buy
+2,249
New +$20.5K ﹤0.01% 1163
2022
Q4 		– Sell
-1,207
Closed -$104K – 1907
2022
Q3 		$104K Buy
+1,207
New +$117K 0.01% 1074
2022
Q2 		– Sell
-2,001
Closed -$333K – 1832
2022
Q1 		$333K Buy
+2,001
New +$287K 0.02% 545

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Virtu Financial's KZR Position: Q3 2024 in Review

Virtu Financial sold out of Kezar Life Sciences (KZR) in Q3 2024, closing a stake of 3,566 shares — an estimated $21K sold.

Virtu Financial first reported a position in KZR in Q1 2022 and held it in 4 quarters. The position peaked at $333K in Q1 2022. 59 funds tracked by Wall St. Rank hold KZR as of Q3 2024.

  • Virtu Financial reported no remaining Kezar Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 3,566 Kezar Life Sciences shares in Q3 2024, an estimated $21K.
  • Virtu Financial first reported a position in Kezar Life Sciences in Q1 2022 and held it in 4 quarters.
  • Virtu Financial's Kezar Life Sciences position peaked at $333K in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.